Signalling and pharmacological properties of the P2Y receptor.
about
The purinergic neurotransmitter revisited: a single substance or multiple players?Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5'-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic DrugsCellular function and molecular structure of ecto-nucleotidases.Pericellular pH homeostasis is a primary function of the Warburg effect: inversion of metabolic systems to control lactate steady state in tumor cells.Nucleotide signalling during inflammationExploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probesCoupling of P2Y receptors to G proteins and other signaling pathwaysRenal intercalated cells sense and mediate inflammation via the P2Y14 receptor.Distribution of ecto-nucleotidases in mouse sensory circuits suggests roles for nucleoside triphosphate diphosphohydrolase-3 in nociception and mechanoreception.The impact of commercially available purinergic ligands on purinergic signalling research.UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactionsThe UDP-sugar-sensing P2Y(14) receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils.Molecular Structure of P2Y Receptors: Mutagenesis, Modeling, and Chemical Probes.Regulation of Vascular and Renal Function by Metabolite ReceptorsA selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.Differential expression of genes related to purinergic signaling in smooth muscle cells, PDGFRα-positive cells, and interstitial cells of Cajal in the murine colon.UDP-glucose promotes neutrophil recruitment in the lung.Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.Novel vasocontractile role of the P2Y₁₄ receptor: characterization of its signalling in porcine isolated pancreatic arteries.Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation.Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.Purinergic signaling in the ovary.Using antibodies against P2Y and P2X receptors in purinergic signaling researchExtracellular UDP-glucose activates P2Y14 Receptor and Induces Signal Transducer and Activator of Transcription 3 (STAT3) Tyr705 phosphorylation and binding to hyaluronan synthase 2 (HAS2) promoter, stimulating hyaluronan synthesis of keratinocytes.UDP-sugars activate P2Y14 receptors to mediate vasoconstriction of the porcine coronary artery.Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling.UDP-Glucose: A Potential Signaling Molecule in Plants?Expression of Adenosine A2B Receptor and Adenosine Deaminase in Rabbit Gastric Mucosa ECL Cells.Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors.P2Y6 Receptors Regulate CXCL10 Expression and Secretion in Mouse Intestinal Epithelial Cells.
P2860
Q26824817-F352FDD9-76F1-482E-9E20-1C693A719763Q28547426-EAC65B42-17A5-453A-B8DC-0BFFA0C651C7Q34031794-38E07C30-0B55-493A-83E7-0ABD4F90D866Q34154991-98459CD6-1243-410A-8F4D-110CBC32B529Q34464511-D8C78171-6CE1-4B67-9AD7-53CCE9543B44Q34756832-C7B8EE60-51FD-4525-8F18-ACDBFFCF3ED4Q35174507-93621F6F-6D8C-42BD-9072-B4180BD6B385Q35208204-38248B7D-F038-439D-84B9-CF6691D440D3Q35250841-0A24E81A-9B36-4A06-AFA9-CA18526C1B4CQ35693550-497CF055-185B-4C7B-9DCF-9E5B7D9EDED4Q35745912-A7B79D90-29A6-400E-9B10-A7930BCCEE51Q35987700-AA11A408-82C5-48BE-9BAD-53161E11B9A1Q36308957-C508D62D-6FF0-4281-ADA5-C1F4F8A5CA4CQ36541370-2FFD83DA-6D4B-449D-BDAD-364469719846Q36752430-FC9B9B00-6945-4976-801F-9F90DA60B87FQ36935278-7294BE17-CCE7-4EB6-B3CB-EC57145892A8Q37075789-0611EC4C-0F13-4DD1-9B99-69C65EF22ABCQ37442041-75A3AB2A-18A5-447B-8AC3-5DF6EBA8BF4CQ37462648-AC619391-2C4B-4E77-9271-F971406D6DA7Q37671297-814AF85F-4920-4F44-84B9-C11E9B60E1BDQ37688371-08B0C5FD-1965-406A-BECD-6ED5948A0360Q38151563-77D4206F-641F-41F4-A07E-BA1B6AE21120Q38566837-6AD4F5AC-B645-44CF-A5DE-7781DCAB3E62Q40643519-76C037AD-673E-4DF4-9EF9-17F0D61644FAQ42826562-B0C9E679-DE83-4419-8D25-F6C0FB08D32EQ47280784-B6F56B93-8EE0-4B21-884B-3AD10F7560EDQ47822741-2C7EEF2C-E103-42ED-8D38-268DDB6C2FA6Q49437191-60B99118-B028-44A6-90DB-1B41DA7DEBC3Q51052316-BEA8C655-6816-464B-8BEA-2592E757D69EQ54986388-139DD4AC-AECF-4B9F-A330-61FC6EB9C512Q55021550-9564F065-52C2-4E61-80B8-107C36DECE09
P2860
Signalling and pharmacological properties of the P2Y receptor.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Signalling and pharmacological properties of the P2Y receptor.
@ast
Signalling and pharmacological properties of the P2Y receptor.
@en
Signalling and pharmacological properties of the P2Y receptor.
@nl
type
label
Signalling and pharmacological properties of the P2Y receptor.
@ast
Signalling and pharmacological properties of the P2Y receptor.
@en
Signalling and pharmacological properties of the P2Y receptor.
@nl
prefLabel
Signalling and pharmacological properties of the P2Y receptor.
@ast
Signalling and pharmacological properties of the P2Y receptor.
@en
Signalling and pharmacological properties of the P2Y receptor.
@nl
P2093
P2860
P1433
P1476
Signalling and pharmacological properties of the P2Y receptor.
@en
P2093
E R Lazarowski
I P Fricks
T K Harden
P2860
P304
P356
10.1111/J.1748-1716.2010.02116.X
P577
2010-03-24T00:00:00Z